Retinoblastoma: from discovery to clinical management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retinoblastoma: from discovery to clinical management

Published:2021-06-15 Issue: Volume: Page:
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Martínez‐Sánchez Mayra¹,Hernandez‐Monge Jesús²,Rangel Martha³,Olivares‐Illana Vanesa¹^ORCID

Affiliation:

1. Laboratorio de Interacciones Biomoleculares y Cancer Instituto de Física Universidad Autónoma de San Luis Potosí Mexico

2. Catedra CONACyT – Laboratorio de Biomarcadores Moleculares Instituto de Física Universidad Autónoma de San Luis Potosí Mexico

3. Departamento de Oftalmología. Hospital Central “Ignacio Morones Prieto” San Luis Potosí Mexico

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.16035

Reference96 articles.

1. The story of retinoblastoma. The XX Edward Jackson Memorial Lecture;Dunphy EB;Am J Ophthalmol,1964

2. From fungus haematodes to retinoblastoma;Moschos MM;J BUON,2017

3. Historic review of retinoblastoma;Albert DM;Ophthalmology,1987

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma;Current Issues in Molecular Biology;2024-05-27

2. An anti-GD2 aptamer-based bifunctional spherical nucleic acid nanoplatform for synergistic therapy targeting MDM2 for retinoblastoma;Biomedicine & Pharmacotherapy;2024-05

3. Nanotechnology-based strategies overcoming the challenges of retinoblastoma: a comprehensive overview and future perspectives;Future Journal of Pharmaceutical Sciences;2024-02-09

4. Investigation of PACAP38 and PAC1 Receptor Expression in Human Retinoblastoma and the Effect of PACAP38 Administration on Human Y-79 Retinoblastoma Cells;Life;2024-01-26

5. Pädiatrische Krebserkrankungen;Molekularbiologie menschlicher Krebserkrankungen;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3